Malantig, Dianah Jane O.
HRN: 16-26-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2025
CEFTRIAXONE 1G (VIAL)
02/20/2025
02/26/2025
IV
1.8g
OD
Acute Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes